NCT04692896

Brief Summary

Lidocaine has been used along with adrenaline in tumescent anesthesia for a variety of procedures. This has been quite popular especially in wide awake surgery of the hand with no tourniquet. However, the appropriate lidocaine concentration is yet to be established. This randomized control trial will study the minimum effective lidocaine concentration in hand surgery using the tumescent technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2017

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2018

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
Last Updated

January 5, 2021

Status Verified

December 1, 2020

Enrollment Period

7 months

First QC Date

December 27, 2020

Last Update Submit

December 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • total duration of analgesia

    Patients were randomized to either 0.1percent, 0.2 percent and 0.3 percent groups. Tumescent local anesthesia was infiltered. Surgery was started approximately 25 minutes after the infiltration. Start of surgery was designated 0 minute. Duration of pain free surgery was noted in minutes. Pain scores was measured after surgery. When pain scores was equal to or more than 4, analgesia was given and total time in minute from start of surgery till this time was taken as total duration of analgesia.

    Within 24 hours of randomization.

Study Arms (3)

0.1% lidocaine

EXPERIMENTAL
Drug: lidocaine

0.2% lidocaine

EXPERIMENTAL
Drug: lidocaine

0.3% lidocaine

EXPERIMENTAL
Drug: lidocaine

Interventions

different concentrations of lidocaine with same concentration of adrenaline

Also known as: adrenaline
0.1% lidocaine0.2% lidocaine0.3% lidocaine

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients aged 16 to 60 years of either gender
  • Patients with post burn/post traumatic contractures involving fingers \& palm
  • Patients with nerve injury or flexor/extensor tendons injury distal to mid forearm.

You may not qualify if:

  • Patients with history of ischemic heart disease, chronic liver disease (ALT/AST 40 IU/L), renal disease (creatinine 13mg/dl), bleeding disorder, peripheral arterial disease \& peripheral neuro3pathy .
  • Surgical site infection .
  • History of allergic hypersensitivity to epinephrine or lidocaine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of plastic Surgery,Mayo Hospital King Edward Medical University

Lahore, Pujab, 54000, Pakistan

Location

MeSH Terms

Interventions

LidocaineEpinephrine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Plastic Surgery

Study Record Dates

First Submitted

December 27, 2020

First Posted

January 5, 2021

Study Start

September 1, 2017

Primary Completion

March 31, 2018

Study Completion

March 31, 2018

Last Updated

January 5, 2021

Record last verified: 2020-12

Locations